F.D.A. Panel Weighs Preventive Use of H.I.V. Drug

Thursday, May 10, 2012 - 15:00 in Health & Medicine

With 50,000 new cases each year in the United States, government advisers are considering whether Truvada, an antiviral medicine, should be given to healthy people at high risk of infection.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net